PRIMARY ENDPOINT As the primary endpoint, we will assess the consequences of vaping EC liquid with no nicotine (NFEC) on cystic fibrosis transmembrane (CFTR)- and calcium-activated chloride channel (CaCC)-mediated chloride conductance in lifetime non-smokers using nasal potential difference (NPD) measurements.